Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Saynor, Richard

Employees

20,000

Website

www.sandoz.com

IPO Date

2023-10-03

Headquarters

Centralbahnstrasse 4, Basel, Basel-Stadt, 4051, Switzerland

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Sandoz Group SDZ

Sandoz Group Earnings Call Summary

Sandoz Group Earnings

Transcripts

Events

About Sandoz Group AG

Sandoz Group
SDZ